Curr Opin Immunol 2013 Oct 7;25(5):579-87. Epub 2013 Sep 7.
Division of Immunoregulation, MRC National Institute for Medical Research, London NW7 1AA, UK; Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, St. Mary's Hospital, London W2 1NY, UK.
Tuberculosis (TB) remains a disease of considerable mortality and morbidity. Studies employing microarrays to derive transcriptional profiles of the host response during TB, which combined with data from experimental systems have highlighted a potentially detrimental role for type I interferons during infection, with important implications for vaccine and therapeutic development. In addition, these studies have provided candidate biomarkers which may advance diagnosis and treatment monitoring. These studies thus exemplify the promise of a systems biology approach to study complex infectious disease such as TB.